Trevena Inc.
16
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
12.5%
2 terminated/withdrawn out of 16 trials
87.5%
+1.0% vs industry average
19%
3 trials in Phase 3/4
43%
6 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250
Role: lead
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
Role: lead
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
Role: lead
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
Role: lead
A Study of TRV130 for the Treatment of Pain After Bunionectomy
Role: lead
A Study of TRV130 for the Treatment of Pain After Abdominoplasty
Role: lead
A Pilot Study of TRV130 for the Treatment of Fracture Pain
Role: lead
A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure
Role: lead
Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure
Role: lead
Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals
Role: lead
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
Role: lead
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects
Role: lead
A Safety, Tolerability, PD and PK Study in Healthy Adults
Role: lead
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
Role: lead
Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
Role: lead
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
Role: lead
All 16 trials loaded